Using Raman spectroscopy to characterize biological materials by Butler, Holly J. et al.
1	  
	  
Using Raman spectroscopy to characterise biological materials 
Holly J. Butler1,2, Lorna Ashton3, Benjamin Bird4, Gianfelice Cinque5, Kelly Curtis6, Jennifer 
Dorney6, Karen Esmonde-White7, Nigel J. Fullwood8, Benjamin Gardner6, Pierre L. Martin-
Hirsch1, Michael J. Walsh9, Martin R. McAinsh1*, Nicholas Stone6*, Francis L. Martin1* 
1Lancaster Environment Centre, Lancaster University, Lancaster, UK;  2Centre for Global 
Eco-Innovation, Lancaster Environment Centre, Lancaster University, Lancaster, UK; 
3Department of Chemistry, Lancaster University, Lancaster, UK; 4Daylight Solutions, San 
Diego, CA, USA; 5Diamond Light Source, Harwell Science and Innovation Campus, Chilton, 
Oxfordshire, UK; 6Biomedical Physics, Physics and Astronomy, University of Exeter, Exeter, 
UK; 7Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, 
MI, USA; 8Biomedical and Life Sciences, School of Health and Medicine, Lancaster 
University, Lancaster, UK; 9Department of Pathology and, Department of Bioengineering, 
University of Illinois at Chicago, Chicago, IL, USA. 
 
 
* Corresponding authors: Prof. Francis L Martin PhD, Centre for Biophotonics, Lancaster 
Environment Centre, Lancaster University, Lancaster LA1 4YQ, UK; E-mail: 
f.martin@lancaster.ac.uk; Tel.: +44 (0)1524 510206; Dr Martin R. McAinsh  
m.mcainsh@lancaster.ac.uk; Prof Nicholas Stone n.stone@exeter.ac.uk 
 
 
Co-author e-mail addresses: 
Lorna Ashton - l.ashton@lancaster.ac.uk 
Holly J. Butler - h.butler@lancaster.ac.uk 
Benjamin Bird - bbird@daylightsolutions.com 
Gianfelice Cinque - gianfelice.cinque@diamond.ac.uk   
Kelly Curtis - kmc217@exeter.ac.uk 
Jennifer Dorney - J.Dorney@exeter.ac.uk 
Karen Esmonde-White - kareshni@umich.edu 
Nigel J. Fullwood - n.fullwood@lancaster.ac.uk 
Benjamin Gardner - B.Gardner@exeter.ac.uk 
Pierre L. Martin-Hirsch - martin.hirsch@mac.com 





Raman spectroscopy is an optical technique that measures the chemical composition and 
molecular structure of a sample. Utilisation of the “molecular fingerprint” of Raman spectra 
has proven an effective analytical approach in geology, semiconductor, materials and 
polymer science fields. The application of Raman spectroscopy and microscopy within 
biology is rapidly increasing and it has proven to be a valuable analytical tool for various 
applications. The technique does not typically suffer from interference from water molecules, 
and therefore biological materials are ideally suited to this spectroscopic approach even with 
interference from tissue auto-fluorescence. Analysis does not conventionally require 
extensive sample preparation and allows for the label-free extraction of biochemical and 
structural information. We describe a protocol for acquiring Raman spectra, maps and images 
from a range of biological samples, and explore a robust approach for sample preparation, 
instrumentation, acquisition parameters and data processing. In this protocol we aim to 
standardise and bring together multiple experimental approaches from key leaders in the 
field. Using this standardised approach, we expect that a typical Raman experiment can be 








Raman spectroscopy has been shown to be a powerful analytical technique in the study of 
biological materials, allowing rapid, non-invasive and high spatial resolution acquisition of 
biochemical and structural information through the generation of point spectra or spectral 
images. Although traditionally used for analytical chemistry applications, there has been a 
significant rise in the use of this technique within biological studies, particularly in the field 
of biomedicine1-4. 
Raman spectroscopy 
Raman spectroscopy utilises monochromatic light, often in the near infra-red (NIR), visible 
or ultraviolet (UV) range, to exploit the phenomena of inelastic scattering, or Raman effect, 
that describes the excitation of photons to virtual energy states and the resultant loss (Stokes) 
or gain (anti-Stokes) of energy that occurs due to the interaction of light with vibrational 
modes associated to chemical bonds within the sample. This shift in energy is indicative of 
discreet vibrational modes of polarisable molecules, and thus a qualitative measurement of 
biochemical composition can be obtained. Raman spectra can infer quantitative information 
provided that the instrument response function is adequately corrected. Typically, the 
significant regions of the Raman spectrum that are observed within biological specimens fall 
within 400 - 2000 cm-1 wavenumbers, associated with bond vibrations of proteins (1500 - 
1700 cm-1), carbohydrates (470 - 1200 cm-1), phosphate groups of DNA (980, 1080 and 1240 
cm-1) and additional cellular biomolecules1,5. Higher frequency bond vibrations associated 
with CH, NH and OH stretching in lipids and proteins can also be observed at higher 
wavenumbers (2700 - 3500 cm-1)5. Consequently, a distinctive biological ‘fingerprint’ is 
derived from the biological sample under investigation and can contribute to our 
understanding of the specimen. Figure 1 illustrates the principle of elastic (Rayleigh) and 
inelastic scattering when analysing biological specimens. 
Raman spectroscopy has a high molecular specificity, making it an excellent technique for 
materials analysis. However, Raman scattering is a rare phenomenon with an exceptionally 
low probability of occurrence (~1 in 108) in comparison with its counterpart Rayleigh 
scattering, and thus is typically described as an insensitive technique. Its increased 
applicability is largely attributed to technological advancement of highly efficient laser 
sources, low-noise detectors, effective Rayleigh filters, and high-throughput optics6. The 
development of microspectrometers, combining the power of optical magnification and direct 
visualisation of the sample with the derivation of corresponding spectral fingerprints, have 
also contributed to further exploitation in biological fields. Due to this, it is possible to not 
only derive single point spectra, but also to produce highly informative Raman images of the 
sampling area with improved interpretability7. The ability to acquire high quality spectra at 
sub-cellular resolution coupled with the capability to obtain valuable information non-
invasively, label-free and without interference from water, makes Raman spectroscopy an 
ideal approach for in vivo biological investigations. 
There are many factors that influence spectral resolution which are outlined in detail in this 
protocol. Whereas, the spatial resolution of optical Raman microspectroscopy is governed 
mainly by the diffraction limit of light, and therefore is dependent upon the laser wavelength 
(l) in use as well as to the numerical aperture (NA) of the objective. Theoretically, for a 
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confocal microscope the diffraction limit for visible (l - 488 nm) to near IR (~1033 nm) and 
from long-working distance to water/oil immersion objectives with NA from 0.5 - 1.2 would 
be in the range of 0.2 to 1 micrometre. In practise, it is rarely possible to achieve the 
diffraction limit both due to imperfect optics and beam scattering at the interface of the 
sample. However, the use of alternative sampling modes such as surface-enhanced Raman 
scattering (SERS) and tip-enhanced Raman spectroscopy (TERS) have been shown to 
provide spatial resolution below the diffraction limit as targeted single molecule detection is 
possible8,9. This is due to the interaction of biomolecules with roughened surfaces, such as 
metallic nanoparticles, that effectively enhance the electric field by a factor of up to 1014. 
This is associated in part to the excitation of localised surface plasmons, known as the 
electromagnetic theory, as well as the charge transfer between the two materials. 
A typical Raman study can rapidly accumulate a large, information-rich spectral dataset. 
However, as this dataset expands, the extraction of biological information becomes 
increasingly challenging. For this reason, multivariate analysis approaches are often 
employed in order to effectively extricate the underlying chemical and structural 
information10. Spectral datasets often present a significant computational burden and thus 
analysis usually includes a data reduction step, particularly as there are many covariant 
features in the spectra. This information can then be fed into unsupervised (clustering) or 
supervised classification to differentiate individual spectra, which can then infer biological 
information11. Raman imaging (global illumination) and mapping (step-wise) have 
particularly benefitted from these classification capabilities, as spectral discrimination is 
indicative of the underlying biological architecture, which has proved valuable in the field of 
cancer diagnosis, where this approach has assisted conventional histopathological 
techniques12. 
Applications 
Raman spectroscopy presents a method of sample examination with a high degree of 
flexibility enabling data to be recorded from a diverse array of sample types including fixed, 
fresh or live tissues and cells. The application of Raman spectroscopy to characterise 
biological materials is a rapidly expanding field and has been used in the field of 
pharmacology13-15, microbiology16-20, toxicology21,22, plant science23-25 and human biology. 
Considerable advances have been made, particularly in regards to cancer diagnosis and 
prognosis26, with clinical implementation firmly on the horizon27, spearheaded by recently 
formed networks such as ‘Raman4Clinics’ (www.raman4clinics.eu/) and Clinical Infrared 
and Raman Spectroscopy for Medical Diagnosis (CLIRSPEC - www.clirspec.org/). Raman 
spectroscopy and its derivatives coupled with multivariate analysis can classify neoplasia in 
brain28-31, breast32, bladder33, colorectal34,35, larynx36, lung37, lymph nodes38,39, oesophageal40-
42, prostate43-46, uterine and cervical47-50 tissues using both point spectra and imaging 
approaches. These examples have employed a range of sample formats, including fixed cells 
and tissues, in vivo measurements with advances in fibre optic attachments and spatially 
offset Raman spectroscopy (SORS), as well as non-invasive biofluids measurements51. In 
addition to cancer studies, the technique has been employed to shed light upon infectious 
diseases such as malaria52-55. Due to the relatively fast sampling time and mapping ability of 
Raman microspectroscopy in aqueous environments, the 2D and 3D analysis of in vitro 




The application of SERS has been shown to vastly improve the spectral intensity obtained 
from typically weak Raman scatterers, such as dilute biofluids62. SERS has been employed 
across a wide range of biomedical studies, including DNA and drug detection63-66. This 
approach has also been shown to overcome autofluorescence, which has often limited 
research capabilities in samples with intrinsic fluorescence, like chlorophyll in plants, as this 
strong signal can often engulf the relatively rare Raman event24. Reduced Raman 
performance in plant research has significantly restricted its application in this area, with 
previous research focused on quantification and identification of plant constituents67-72, as 
well as imaging of non-fluorescent tissues25,73-75. As fluorescence has a defined wavelength 
profile, it is also possible to overcome fluorescence by employing alternative radiation 
sources using lasers at wavelengths outside typical biological matrix absorbance e.g. in the 
NIR (1064 nm) region76. Water has also been found to be a significant fluorescence quencher, 
which has benefitted in vivo studies, recently demonstrated in fundamental plant 
monitoring77,78.  
Limitations 
The molecular specificity of Raman spectroscopy is powerful for the study of biological 
materials. However, there are a number of disadvantages associated with the technique. Since 
Raman scattering is a relatively low probability event; low sensitivity can be an issue, which 
is exacerbated by interference from fluorescence13. Due to the intense laser powers typically 
used, local thermal decomposition of the sample may be encountered, especially when using 
UV or visible wavelengths. Sample burning (or photoablation) may be observed visibly by 
dark areas on the sample and spectroscopically by the presence of amorphous carbon bands 
(C=C ~1500 cm-1) in the spectra, or saturation of the detector. The protocol described here 
will provide troubleshooting advice to avoid these particular issues. Fourier transform 
infrared (FTIR) spectroscopy is an alternative vibrational spectroscopy technique that is also 
suitable for analysis of biological materials (for a recent protocol, see Baker et al79). Although 
based on fundamentally different physical excitation processes, FTIR retains both molecular 
specificity and sensitivity, and has thus been employed to derive spectral data and elucidate 
biological information, complementary to Raman spectroscopy80-82. 
The aim of this article is to describe a specific protocol for Raman spectroscopy that can be 
applied to a variety of biological samples independent of the specific manufacturer 
instrumentation and software. The protocol will address (i) sample preparation, (ii) spectral 
acquisition, and (iii) data analysis of spectral datasets with anticipated results derived from a 
range of biological studies (Fig. 2). It is important to note that this technique can also be 
applied to non-biological materials, providing insights into the steps involved in Raman 
studies. In this protocol we approach principal aspects of planning and implementing Raman 
investigations that can be applied to a variety of biological samples. We direct the reader to 
additional protocols that approach specific biological applications75,83-86. It is our aim that by 
unifying protocols from leading researchers in the field, spectroscopists and biologists can 
build new interdisciplinary studies into biological samples incorporating Raman spectroscopy 




Experimental design: instrument options 
When conducting a biological study using Raman spectroscopy it is important to first 
consider the investigative aims (exploratory versus diagnostic) and the desired analytical 
goals (imaging, classification for diagnosis, pattern finding, and biomarker identification)79,87. 
Furthermore, the constraints of the sample under investigation must be addressed (e.g., 
format, impurities) and the consequent suitability of different Raman substrates (e.g., quartz, 
metal-coated glass, calcium fluoride). Figure 3 presents an overview of a typical Raman 
system and identifies key instrumental components. There are numerous Raman 
spectroscopic variations available, as described in Table 1. This protocol will focus primarily 
upon spontaneous Raman microspectroscopy. 
Excitation source. It is possible to use a variety of excitation sources to irradiate samples, 
dependent on the suitability of the specimen to increased photon energies and the sensitivity 
and resolution required in the study. Broadly speaking there are three main factors to consider 
when choosing a laser system: (i) source, (ii) wavelength, and (iii) spot size. There are several 
laser source options available within Raman systems, of which diode lasers are increasingly 
commonplace, particularly within biological systems. Diode lasers are based upon solid or 
semi-conductor technology and consequently provide greater energy efficiency than their 
popular noble gas-based counterparts88,89. Although gas-based lasers have been frequently 
used in laser-based technologies, they are restricted by a finite lifetime. A helium neon 
(HeNe) laser has a relatively low power output in comparison to diode lasers, and more 
powerful alternatives, such as the argon-ion laser, discharge large amounts of heat that 
requires a cooling system to counteract, which is energy inefficient and also reduces 
portability88. The introduction of diode-based lasers has contributed to the development of 
portable Raman systems due to their durability and compactness90,91. When choosing a laser 
source, it is also important to consider if the experiment requires the use of pulsed (e.g., 
neodymium-doped yttrium aluminium garnet [Nd:YAG]) rather than continuous wave lasers 
(e.g., Krypton ion laser). Line width of the laser is also an important consideration as it has a 
direct influence upon the spectral resolution, regardless on spectrometer configuration. 
Generally, gas-based and solid-state lasers have narrow bandwidths, whereas some multi-
mode diode lasers can have wide bandwidth with broad spontaneous emission.  
The wavelength of the laser is critical to the experimental design (Fig. 4). Wavelengths 
available are laser specific, yet generally fall between the mid UV (>200 nm) and the NIR 
(<1.1 µm). As mentioned previously, it is possible to suppress fluorescence using NIR 
wavelengths, due to the use of relatively low energy photons. Similarly, UV wavelengths can 
be employed as the fluorescence is red-shifted beyond the fingerprint region of the Raman 
spectrum, and therefore is comparatively free from fluorescence, despite much higher energy 
wavelengths76. A key constraint to consider is the interaction between the laser wavelength 
and the sample, due to the effects of phototoxicity. High energy or prolonged exposure to 
light can have a destructive effect on samples, particularly in vivo studies and interrogation of 
sensitive samples such as single cells. It is advised to reduce exposure times wherever 
possible and to conduct adequate controls to determine toxic effects of the laser wavelength 
in use. 
In addition, it is important to consider the effect that laser wavelength has on other key 
experimental parameters such as resolution and sensitivity. The spatial resolution is 
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dependent on wavelength of the laser, due to the determination of the laser spot size. 
Sensitivity is also dependent upon the excitation wavelength, as the Raman scattering 
intensity is proportional to 1/λ4 resulting at significantly reduced sensitivity at lower laser 
photon energies, such as the 1064 nm laser wavelength. 
NIR lasers, most commonly 785 nm and 830nm, have been extensively applied in biological 
studies, particularly fixed and live cells, as the lasers have relatively low photon energy and 
generally do not cause substantial photodamage92-95. Tissue Raman spectroscopy is also 
typically performed in the NIR because it is within the diagnostic window of low melanin 
and water absorption96. Excitation in the UV region has been particularly useful in resonance 
Raman studies of biological materials, due to the similarity between the laser wavelength 
frequency and the electronic transition of the molecule under investigation97,98. The total laser 
power onto the sample is central for acquiring high quality results from biological samples 
given that they are generally low scattering materials and suffer from radiation damaging. 
Practically, it is better to have >30 mW laser power at the source for the shorter visible 
wavelengths and >100 mW for the longer ones, then use a series of attenuators to optimize 
the illumination power delivered at the specimen. It is important to consider this last point, as 
the laser intensity is dependent upon laser spot size (sampling area) and magnification and 
can have a significant impact on laser exposure on the sample. 
It is possible to alter the profile of the laser spot in some Raman systems, which can also be 
beneficial depending on the experimental parameters and overall investigative aims. By 
focusing the laser in a line, a larger surface area is illuminated, maximising the Raman 
scattered light, which in turn derives spectral information from a larger surface area as well as 
preventing photodamage99. Line mapping by raster scanning the line focused laser across the 
sample, can obtain Raman maps with improved acquisition times, without compromising 
image quality83,100-102. The intensity across the laser line is variable and therefore this 
approach leads to spectra with variable signal to noise across the laser line. An alternative is 
to globally illuminate the sample area, resulting in high quality spectral imaging with 
enhanced power distribution across the sample103,104. Specialised filters (e.g., liquid-crystal 
tunable, dielectric, acousto-optic filters) are used to actively select specific wavelengths, 
which along with a 2D detector allows the production of true Raman images from relatively 
flat samples101. Although global illumination allows for high quality spectral imaging, this 
often comes at a cost of spectral quality due to the reduced laser intensities across the 
sampling area. 
Detector. In order to detect the weak intensity of scattering, the detector included in the 
Raman system needs to be extremely sensitive. Greater levels of sensitivity may be necessary 
in some studies where scattering is especially weak, or where noise is particularly high and 
thus the challenge of detection is increased. Charge coupled devices (CCDs) are commonly 
integrated in Raman systems because they exhibit high quantum efficiencies and low signal-
to-noise (SNR), compared to early alternative detectors such as photomultiplier tubes (PMT) 
and photodiode array (PDA)105. CCDs are multichannel arrays made up of made up of 
thousands of pixels, each of which can collect charge from scattered photons106. This charge 
is then passed through adjacent pixels, until they are readout individually, relating directly to 
the scattering intensity. There are a range of CCD choices available, including intensified 
CCDs (ICCDs) and electron multiplying CCDs (EMCCDs). At extremely low scattering 
intensities, EMCCDs can provide superior sensitivity than conventional CCDs due to creation 
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of further electrons and therefore providing a signal relatively higher than the readout noise. 
Although, if spectra are shot or Poisson noise limited, the use of an EMCCD will not improve 
SNR107. Dark, or thermal, noise can be dramatically improved by detector cooling, often 
using liquid nitrogen cryogenic or thermoelectric Peltier cooling, with deep cooling toward -
80 - 100°C providing up to one order of magnitude improved noise reduction108. The 
quantum efficiency of the silicon based CCD detectors is wavelength dependent and drops 
off rapidly in the NIR region. In back-illuminated CCDs this can result in fringing effects as 
the detector effectively behaves as an étalon. Longer wavelengths of light that are not 
effectively absorbed by the photosensitive region of the detector are instead reflected 
throughout the detector, with detrimental effects upon spectral quality. This can be somewhat 
overcome by using deep depletion CCDs. For NIR studies beyond 950 nm, where the photon 
energy is less than the silicon bandgap, NIR detectors such as an indium gallium arsenide 
(InGaAs) detector are advantageous to overcome thermally generated noise in the higher 
wavelength region109. 
Additional hardware. Rayleigh scattering is more intense than Raman scattering and can 
easily overpower the more informative signal so it must be optically filtered. Dispersive 
Raman spectrometers use specialised Rayleigh filters or a multistage monochromator, 
whereas non-dispersive spectrometers often employ Fourier transformation (FT) based on a 
Michaelson interferometer109. There are a range of manufacturer-specific Rayleigh filters 
available110, however holographic notch and dielectric edge filters are most commonly used. 
Edge filters transmit light wavelengths above that of the laser in use, whereas notch filters 
will effectively filter only the laser wavelength, allowing both Stokes and anti-Stokes 
measurements111. Metal oxide edge filters have been shown to have much longer lifetimes 
than notch filters. Rayleigh filters must be selected to be specific to the laser wavelength. In 
contrast, a multistage monochromator can be used with variable laser wavelengths although 
there is a major throughput disadvantage to using multistage monochromators6. Single 
monochromators are comprised of a diffraction grating, used to disperse the Raman scattered 
light and are universally used in conjunction with Rayleigh filters. Gratings differ due to the 
number of grooves (g/mm) or lines (l/mm) on the surface, which can be anywhere in the 
range of 150 - 4000 per mm, corresponding to the diffraction, or angular dispersion 
capabilities of the grating. Higher groove frequency can improve the spectral resolution at the 
cost of reduced spectral intensity and range. The sampling aperture of the system determines 
how much light, and therefore Raman scatter, is passed through the spectrometer. Slits and 
pinholes range from 10 µm to 100 µm, with a larger aperture allowing more light through the 
system and thus increasing sensitivity, but at the expense of spectral and depth resolution. For 
thin samples liked fixed cells the use of pinhole and optimal in-depth focus of the laser 
illumination is crucial to maximize the Raman signal from the sample volume. 
The choice of microscope objective is crucial in Raman microspectroscopy. The objective’s 
throughput depends on its magnification and solid angle of light collection i.e. NA. A high 
magnification/high NA objective provides higher axial spatial resolution but has a shorter 
working distance and may be better suited for thin samples. Low magnification/moderate NA 
objectives provide lower axial spatial resolution but have a longer working distance and may 
be better suited for bulky specimens to avoid the specimen touching the objective. Low 
magnification may be more appropriate for samples that do not require high spatial 
resolution, such as liquids and homogenous samples. Conversely, high magnification is 
beneficial in studies that require high spatial resolution so that specific biological architecture 
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can be examined. Importantly, microscope objectives can be specially coated for optimal 
performance in a specific wavelength region and those coatings can produce significant 
background signals if another wavelength is used. We encourage careful consideration of the 
microscope objective and additional preliminary tests with the sample under investigation. 
Experimental design: sample preparation 
One of the major advantages of Raman microspectroscopy in biological studies is the ability 
to derive label-free and non-destructive spectral information, with minimal sample 
preparation. However, it is important to appreciate sample constraints as well as substrate 
options that can have a significant impact on experimental procedures. As the technique relies 
upon maintaining optical focus, sample stabilisation and relative flatness are important 
sample preparation considerations.  
Sample format. Fixation can be an important step in sample preparation and is often used to 
isolate a sample at a distinct time point or for sample archiving. Formalin-fixed, paraffin-
embedded (FFPE) tissues have been historically archived in pathological settings and 
specimens have been widely analysed using microspectroscopy. Formalin modifies the 
proteins by cross-linking and paraffin has strong signals in the fingerprint and higher 
wavenumber region of the spectrum. These signals can be found at 892, 1065, 1135, 1174, 
1298,  1421, 1443 and 1464 cm-1 and thus have significant overlap with the underlying 
sample biology112. The contributions of paraffin in the Raman spectrum are removed by 
either de-waxing of the sample, which has been shown to have dramatic effect on lipid 
content, or digital de-waxing that can remove the strong paraffin peaks from the spectrum113. 
Analysis of fresh or snap-frozen tissues may overcome these substantial drawbacks although 
sample acquisition becomes more difficult, sectioning is encumbered, and sample 
degradation must be controlled. Lipid alterations are also evident in fixed cells analysed using 
Raman spectroscopy114. Live cell analysis is therefore a rapidly expanding field that allows 
the user to interrogate cells in situ in aqueous environments and 3D cell cultures whilst 
maintaining key growth parameters including temperature and gas availability56. In these 
studies cells should be sufficiently adhered to a growth substrate prior to analysis. Also, the 
background signal from the cell media should also be considered prior to analysis as it may 
provide unwanted background interference. 
Liquid samples can be easily examined using an immersion objective or a microfluidic device 
to overcome spectral artefacts due to the presence of bubbles and surface tension. This has 
permitted the analysis of biofluids, such as blood plasma, sputum, saliva and urine, in 
diagnostic studies51. Another approach for biofluids analysis is a combined drop coating 
deposition Raman spectroscopy (DCDRS), also known as drop deposition/ Raman 
spectroscopy. Small biofluid volumes are deposited onto a flat substrate and allowed to dry 
based on sessile drop formation principles115. Sessile drop formation has many benefits for 
Raman spectroscopy with significant pre-concentration of proteins, coarse separation of 
impurities and reproducible prediction of protein solution concentrations116,117. The resultant 
“coffee ring” dried drop can be examined by Raman microspectroscopy, with the knowledge 
that a variable coffee ring thickness affects spectral intensities and distribution of 
macromolecules within the ring deposit118-120.  
Raman substrates. Substrate choice is a critical factor in experimental design that is 
dependent upon the experimental outputs and sample characteristics. The matrix upon which 
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a sample is supported contributes to stability and therefore directly affects spectral quality by 
maintaining focus. The most significant properties of the substrate to consider are the spectral 
background signals, the substrate cost, availability and composition. Glass slides typically 
used in optical microscopy are exceptionally cost-effective but have a strong background 
fluorescence that limits analysis at excitation wavelengths other than 532 nm121. Another 
approach is to use metal-coated glass slides, such as aluminium or gold-coated glass, which 
effectively eliminates the glass signal. Gold-coated slides with roughened surfaces have also 
been shown to be good SERS substrates122. Calcium fluoride (CaF2) and quartz slides are 
used as Raman substrates due to minimal background interference. Care should be taken in 
choosing a substrate because contaminants can produce unwanted backgrounds. Barium 
fluoride (BaF2) slides have also been used as a Raman (and IR) substrate but their partial 
solubility in water make them unsuitable for in vivo and aqueous studies123. Quartz and fused 
silica are also popular choices for Raman studies. While these speciality substrates are more 
expensive than glass, they are often reusable in a laboratory setting. In a clinical setting, these 
costs may be prohibitive, particularly for large scale screening programs, and we support 
development of low-cost, single-use sterilised Raman substrates. 
Experimental design: spectral acquisition 
The desired spectral output must be considered when approaching spectral acquisition, as 
experimental parameters may be altered between simple point spectra and image 
construction. In general, superior spectral quality can be obtained using a point spectrum 
approach, as datasets can benefit from longer acquisition times. In comparison, hyperspectral 
data cubes generated from mapping and imaging techniques can provide user friendly data 
interpretation, although negotiation between extensive acquisition times, spectral and image 
quality is required101. For example, a map spanning a biological feature 10 x 10 µm in size, 
would be compromised of 100 spectra when using a step size of 1 µm (with over-fitting). 
This map could be acquired relatively quickly when using acquisition times less than 10 
seconds, although some samples may require increased laser exposures due to small volumes 
or weak scattering tendencies such as single cell studies. It is important to note however, that 
huge numbers of poor quality spectra can still provide exquisite detail using multivariate 
approaches. 
Resolution. The desired spectral and spatial resolution of the experiment, and hence the 
required sensitivity, must be decided prior to spectral acquisition. As mentioned with regards 
to instrumentation options, spatial resolution is ultimately diffraction limited and therefore 
linearly dependent on the laser wavelength and inversely with the objective NA. Accordingly, 
high spatial resolutions can be achieved with lasers at shorter wavelengths and high 
magnification optics. 
Spectral resolution is in fact greater at higher excitation wavelengths, providing the Raman 
optical configuration remains constant. Gratings with higher groove frequency can improve 
spectral resolution at a cost to sensitivity and spectral range. An increased number of smaller-
sized pixels within the detector and reduced between pixel cross talk, can also contribute to 
increased spectral resolution124. However, this is often impractical to alter within a single 
Raman system. Spectrometer focal length (SFL) refers to the distance between the diffraction 
grating to the detector typically between 200 - 800 mm, with greater distances generally 
providing improved spectral resolution125. A larger SFL requires a larger entrance slit, in 
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order to allow the maximum passage of light, which can also influence spectral resolution126. 
Although not exhaustive, these factors determine the spectral output and must be considered 
prior to analysis. 
It is evident that when choosing a laser excitation wavelength there is a potential trade-off 
between desired spectral and spatial resolution. High spectral resolution (up to 0.5 cm-1) may 
be required in studies where specific molecular information is required and thus adjacent 
Raman bands need to be differentiated, such as in pharmaceutical studies monitoring drug 
uptake at the cellular level. Increased spatial resolution (up to 1 µm) is required when specific 
localised information is required such as when interrogating tissue features to extract 
biological information. This is particularly valuable in mapping and imaging approaches as 
specific architecture can be imaged, such as when identifying cancer progression in tissue 
samples42,45. 
Calibration. Commercially available instruments output the Raman spectrum in units of 
pixels. The process of calibrating the spectrum from pixels to Raman shift, typically reported 
in wavenumbers, is a multi-step process. We recommend daily calibration of the instrument, 
as even subtle shifts in the instrument optics may produce an observable change in the Raman 
shift. It is important that the user ensures that the laser spot corresponds to the visual and 
spectrometer sampling point preceding sample acquisition. If necessary, beam alignment can 
be performed using manual or computerised beam-steers and should be checked regularly to 
optimise spectral acquisition. Dependent upon the instrument manufacturer, there are manual 
and/or automatic calibration options. The first calibration step is conversion of pixels to 
wavelength. This is achieved by measuring a calibration lamp, such as Neon or Argon that 
has multiple atomic emission lines, and using a non-linear model to fit the spectral peaks to 
the CCD pixel. The second and third steps are converting wavelength to wavenumber units 
but forming the inverse of the wavelength and correction of the laser wavelength using 
reference materials with defined Raman signatures. The easiest reference material to use is 
silicon, which has a sharp peak at 520.5 cm-1 and any band shifts can be easily offset127. Other 
Raman reference materials include cyclohexane, acetaminophen or Teflon. Luminescent or 
broad band emission standards can be used to derive a system response function measure to 
correct for filter, detector etaloning and quantum efficiency effects128. Further performance 
validation tests can include the measurement of a well characterised protein in order to check 
SNR and calibration consistency between measurements. National Institute of Standards and 
Technology (NIST) standards are also routinely used as calibration references. 
Spectral quality. Optimising experimental parameters is an iterative process, requiring an 
element of trial-and-error in order to obtain a method for optimum spectral quality and high 
SNR. Spectral quality is governed by instrumentation, sample suitability and ultimately time 
constraints. Within sampling parameters, it is possible to attenuate the laser power so that 
optimum power levels are incident on the sample providing the highest Raman signal for 
weak scatterers, whilst preventing detector saturation for intense scatterers124. Following 
power adjustments, the exposure time of the laser on the sample can be increased, 
multiplying the intensity of scattered photons and therefore the spectral quality. The user also 
has the option to accumulate multiple spectra, increasing the signal intensity and reducing 
baseline interference. Longer exposure times and co-additions can significantly impact on 




Spectral contamination. Cosmic rays are sporadic background artefacts recognised by 
sensitive detectors, that manifest in Raman spectra as narrow bandwidth spikes129. Most 
instrument software packages contain cosmic ray removal algorithms that allow the user to 
selectively eliminate cosmic rays, as well as algorithms in processing packages for automated 
cosmic ray removal 130. Peaks from known contaminants, such as paraffin in FFPE tissues, 
can be removed using cutting techniques or computational algorithms112. For samples 
containing extrinsic fluorescence, photobleaching could be utilised to suppress interference 
from contaminants. Exposing samples to the incident light source for a few seconds prior to 
acquiring spectra on the detector, effectively ‘bleaching’ the fluorescent contaminants, has 
been shown to reduce oscillating baselines131. 
Experimental design: data processing 
Spectroscopic studies can rapidly generate large datasets that require computational 
processing in order to derive biochemical information. Depending on the specific spectral 
acquisition and experimental objectives, it is possible to extract informative images, spectral 
biomarkers and patterns and also classify samples due to their spectral fingerprint. As a rule, 
data processing can be divided into three distinct steps: (i) dataset pre-processing, (ii) feature 
extraction, and/or (iii) classification79. Table 2 provides a list of available analysis software.  
There is also a strong relationship between Raman and IR spectral analysis (for reviews of 
this technique, see79,87,130,132). 
Pre-processing. Before any further analytical steps, the quality of the spectral datasets should 
be assessed and pre-processing applied to improve the accuracy of the study by minimising 
insignificant variability130. At this point, spectra should be corrected for cosmic rays and the 
quality of the spectra can be visually assessed. There are some circumstances when visual 
inspection of spectra show clear outliers including significant spectral contamination, 
fluorescence or very poor SNR133. In those cases, obvious outliers can be removed from the 
dataset. Other spectra may be outliers in the dataset which may be identified using a Q-test or 
other outlier detecting algorithm to reduce user bias. We recommend sagacious and limited 
removal of spectra from a data set because it has an impact particularly on hyperspectral 
images and small datasets. 
Raman spectra are particularly prone to noise and data may require noise reduction to 
enhance spectral quality. The first approach to improve the quality of the Raman signal 
would be alter spectral acquisition settings, such as using increased integration times and 
higher laser power. Sample preparation may also be adjusted by pre-concentrating or 
photobleaching the sample. If these approaches are inadequate, then spectra can be 
computationally manipulated post-acquisition to improve the SNR. Principal component 
analysis (PCA) is a powerful technique in Raman pre-processing that can effectively reduce 
the spectra into a defined number of principal components (PCs) that account for significant 
spectral variance134. This technique can be employed to reconstruct spectra using only 
significant PCs, therefore retaining important spectral data whilst removing background 
noise135. Another approach is noise reduction by Savitzky-Golay (SG) or kernel smoothing, 
minimum noise fraction transform and wavelet de-noising (WDN) techniques that can filter 
high frequency noise132. While smoothing spectra does reduce the apparent noise, we note 




Sample fluorescence and thermal fluctuations of the CCD can significantly impact on the 
spectral baseline and therefore require baseline correction. Polynomial baseline fitting 
attempts to estimate the unknown background. This is often dependent upon user defined 
polynomial points, and can effectively abolish sloped or oscillatory baselines136,137. Care 
should always be taken with any baseline subtraction routines as they can introduce 
unintended artefacts. Alternatively, 1st or 2nd order differentiation, coupled with SG 
smoothing, can be applied to mathematically remove contributions from scalar offsets or 
baseline slopes, whilst simultaneously resolving overlapped peaks138. Unlike polynomial 
fitting which yields spectra with conventional morphologies, derivative spectra are 
transformed and do not have a regular Raman appearance. 
Following baseline correction spectra may also require normalisation to correct for sample 
and experimental variables, such as thickness and density. Vector normalisation and min-max 
normalisation are two popular methods that can be applied to spectra following any baseline 
correction algorithms without significant impact on spectral features130. Amide I peak 
normalisation is also commonly utilised in IR and Raman studies79. However, this technique 
is not appropriate following differentiation, due to the shift of the typical Amide bands, or for 
observing protein alterations as all values are scaled to 1. 
Finally, an optional data reduction step can be included in the pre-processing procedure to 
optimise statistical analysis. As highlighted previously, large spectral datasets can often 
present a significant computational burden, due to the many absorbance intensities contained 
in a single spectrum. By truncating the spectrum to shorter wavenumber ranges this burden 
can be reduced, especially if the range focuses on individual Raman peaks139. Alternatively, 
data reduction algorithms, such as partial least squares (PLS) or PCA can be employed to 
reduce individual spectra down to a few significant factors and has been widely implemented 
as both a pre-processing and feature extraction step132. 
The selection of pre-processing steps and the order in which they are conducted has been 
shown to have an major impact on the outcomes of spectral analysis, complicating 
development of a universal approach140. Wherever possible we advise the use of derivative 
baseline correction and vector normalisation, although this does require high SNR data, it can 
be particularly effective in diagnostic studies. In addition whenever necessary the use of noise 
and data reduction tools can be applied. 
Feature extraction. In both exploratory and diagnostic studies, it is important to transform 
individual spectra into appropriate variables that confer biological information. Feature 
extraction methods range from very simple, such as defining a band area, to considerably 
more complicated computational functions. Feature extraction can broadly be split into two 
distinct approaches, feature construction and feature selection. These approaches are 
comprehensively reviewed by Trevisan et al132. Briefly, feature construction can be defined 
as the creation of new features in a dataset that can infer otherwise obscured information, for 
example, the previously mentioned linear methods PCA and PLS. This can be exceptionally 
important for diagnostics, biomarker extraction and pattern recognition in otherwise 
homogenous datasets and also play an important role in hyperspectral imaging, as individual 
pixels can be reduced to single values relating to spectral intensity or variance79. Feature 
selection approaches extrapolate existing features from the dataset, such as specific 
wavenumbers, that can be used to determine spectral biomarkers and/or feed into diagnostic 
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frameworks141. Techniques such a genetic algorithm, multivariate curve resolution and 
successive projection algorithm have proven particularly popular as feature extraction 
methods, as only informative variables are included in the resultant model142. 
Classification. Classification of samples based on their spectra is often desirable, in both 
imaging and diagnostic studies, as spectra can be categorised based on prior user input 
(supervised classification) or spectral variance alone (unsupervised). Unsupervised 
classification typically relies upon a clustering technique, of which hierarchical cluster 
analysis, k-means clustering and fuzzy C-means clustering are three popular options80. PCA 
is another unsupervised approach that is commonly used to extract key variables describing 
the largest variance within a dataset. In imaging studies, this approach requires no prior 
knowledge of the sample in question, and produces information-rich pseudo-spectral images 
that are ideal for exploratory studies143. The loadings or spectral features used to calculate the 
scores or weights images can provide key information on molecular distributions in a sample. 
For diagnostic analysis, supervised classification is most commonly used, as the desired 
outputs are dependent upon class labels provided by the user. This could be gold standard 
histopathology, cell type, or an alternative measure of class. These class assignments are 
taken into consideration when implementing the classification technique; using a proportion 
of the dataset, referred to as a ‘training dataset’. A classifier is then able to categorise a 
separate ‘test dataset’ accordingly. It is a common approach to validate the classification 
outputs using an independent dataset. Linear discriminant classifiers (LDC), artificial neural 
networks, and support vector machines (SVM) are particularly common machine learning 
techniques that effectively classify spectral data, although other techniques are available144. 
Semi-supervised classification is an alternative option when some, but not all, data classes 
can be determined145,146. 
Sample size. Classifier performance and validity is highly influenced by sample size and thus 
is an essential aspect of experimental design. The number of spectra within a dataset can 
easily surpass millions, as a sufficient number of spectra per sample and class type is required 
to account for the inherent sample intra- and inter-class variability. However, it must be 
remembered that the number of spectra is not representative of the sample size and frequently 
the number of independent samples is much smaller and may, for example, be determined by 
the overall patient number in a given study. It has been shown that a sample size of between 
75 - 100 is sufficient to train a classification model with good precision and validation147. 
Cross-validation may be a suitable solution in smaller datasets as resampling approaches can 
repeat or iterate different training and test datasets for a defined number of times, effectively 
using as much of the dataset as possible132,148. However, full independent testing of a 








! CAUTION We note that most of the listed reagents are chemicals with potential hazards. 
Users should consult with the chemical’s Material Safety Data Sheet and the appropriate 
facility safety guidelines prior to handling chemicals. Raman spectra for each reagent used 
may be provided by the reagent supplier or accessed via a Raman database provided by the 
instrument manufacturer. 
• Sample acquisition: Fixed tissue, fresh tissue, cryosectioned tissue, fixed cells, live cells, 
biofluids and powders from a variety of biological specimens. 
 ▲ CRITICAL Research carried out with human subjects must be compliant with the 
Helsinki Declaration. Research carried out with animals must be approved by the local 
institutional review board or animal use ethical board. Approvals must be established 
before the experiment’s start. 
• Fixative agents: - 
o Formalin, 10 % (vol/vol) (Sigma-Aldrich, HT5011128) 
o Glutaraldehyde, 25% (vol/vol) (Sigma-Aldrich, G5882) 
o Ethanol (Fisher Scientific, E/0600DF/17) 
o Methanol (Fisher Scientific, A456-212) 
o Acetone (Fisher Scientific, A19-1) 
o Osmium tetroxide, 2% (wt/vol) (Sigma-Aldrich, 75633) 
• Paraffin wax pelletised with added polymers 57-58°C (Fisher Scientific, 12624077) 
• De-waxing agents: - 
o Xylenes (Sigma-Aldrich, 534056) 
o HistoChoice® Clearing Agent (Sigma-Aldrich, H2779) 
• Liquid nitrogen (BOC, CAS no. 7727-37-9) 
• Isopentane (Fisher Scientific, P/1030/08) 
• SERS nanoparticles:- 
o Gold 150 nm (1.66 x 109 particles/ml) (BBI Solutions, EM. GC150) 
o Gold 40 nm (9.00 x 1010 particles/ml) (BBI Solutions, EM. GC40) 
o Silver 40 nm (2.6 x 109 particles/ml) (BBI Solutions, EM. SC40) 
• Virkon® Disinfectant (Fisher Scientific, NC0480633) 
REAGENT SETUP 
• Fixatives: Must be diluted to appropriate concentration using phosphate buffered or saline 
H2O solution. Can be refrigerated at 4°C for several weeks before use. 
• SERS nanoparticles: Require dilution to appropriate concentration dependent upon 
experimental parameters. 
• Biological samples:- 
o Fixed tissue.  Generally, tissues are fixed using an appropriate concentration of 
chemical fixative, followed by alcohol dehydration. Tissues can then be either 
desiccated stored at room temperature (20-22°C) for a number of months, or 
paraffin embedded. An embedding base mould should be filled with molten wax 
using a wax dispenser. The sample should be carefully placed into the wax at the 
desired orientation and allowed to cool. FFPE tissue blocks can be stored at room 
temperature indefinitely. 
o Fresh tissue.  In vitro studies, such as when tissue has been excised from the 
independent sample, will be prone to sample degradation and thus should be 
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analysed as soon after excision as possible. Refrigeration at 4°C or imitating the 
natural environment may be sufficient for several days of storage. Tissues may be 
snap-frozen using liquid nitrogen and isopentane for long term storage with 
minimal effect on sample integrity. 
o Fixed cells. Fixed using appropriate chemical fixative or a preservative buffer and 
can be stored at room temperature. Cells can be gentled centrifuged to form a 
concentrated cell pellet, wherever necessary. 
o Live cells. Dependent upon desired experimental aims, live cells must be kept in 
optimum living conditions throughout the study, including nutrient requirements 
via media, as well as temperature, pH, light and gas conditions. 
o Biofluids. Once obtained, biofluids can be stored at -80°C for several years to 
prevent degradation. Prior to sample preparation, biofluids should be thawed using 
a water bath at 35-37°C. 
EQUIPMENT 
! CAUTION We note that the listed equipment has potential hazards. Users should consult 
with the equipment instruction manual and the appropriate facility safety guidelines prior to 
use. 
• Electronic Equipment: 
o Raman microspectrometer (Table. 3 illustrates a number of commercially available 
systems) 
o Computer system: A standard computer should be sufficient for basic spectral 
acquisition and basic data analysis.  As computational demands rise in correlation 
to data processing with increased complexity, it is advised that a system with 
sufficient RAM access (upwards of 4 GB in 32-bit PCs), and a high-speed 
processor is used. 
• Microtome (Thermo Fisher Scientific, 902100A) 
• Wax dispenser (Electrothermal, MH8523B) 
• Sectioning bath (Electrothermal, MH8517) 
• Centrifuge (Thermo Fisher Scientific, 75002410) 
• Desiccator (Thermo Fisher Scientific, 5311-0250) 
• Substrates:- 
o Glass slides (Fisher Scientific, 12657956) 
o CaF2 slides (Crystran, CAFP10-10-1) 
o Quartz slides (UQG Optics, FQM-2521) 
o Gold-coated slides (Platypus Technologies, AU.0500.ASLI) 
o Aluminium-coated slides (EMF, AL134) 
o Quartz vial (Starna Cells, 1-Q-1) 
• Accessories:- 
o Laser power meter (Coherent, 1098293) 
o Microtome blades (Leica Biosystems, 14035843490) 
o Desiccant (Sigma-Aldrich, 13767) 
o Embedding base moulds (Leica Biosystems, 38VSP58167) 




• Software: Table 3 describes the available software options that come as standard with 
each specific commercial instrument. These software options are essential for spectral 
acquisition and may also provide data processing provisions. However, for specialised 





In the following protocol we focus upon three experimental examples: (i) in vivo spectral 
exploration of live plant samples (suitable for fresh tissue analysis); (ii) Imaging of fixed 
human tissue; and (iii) SERS classification of endometrial cancer using biofluids. 
Sample preparation 
1| Prepare the samples and mount onto appropriate Raman substrates following option (A) for 
in vivo plant analysis; option (B) for FFPE tissue samples; or option (C) for SERS biofluids 
analysis; or option (D) for cell analysis. 
(A)  Plant tissue ● TIMING 5 min 
(i) Obtain plant specimen from sample community.  
(ii)  Place sample upon a suitable Raman substrate (dependent upon thickness of tissue). 
▲CRITICAL Leaf tissue in most plant species should be sufficiently thick to avoid 
background interference from the substrate. However, roots tissues for example may 
require a high quality substrate. 
(iii) Secure sample using a weight, adhesive, or magnetic if using a magnetic stage 
accessory. 
(B) FFPE tissue ● TIMING 30 min + dewaxing (1.5 h) 
(i) Acquire FFPE tissue blocks from pathology laboratory with appropriate ethical 
approval. 
(ii) Place FFPE block upon a cool, preferably frozen surface, for at least 10 minutes. 
▲CRITICAL STEP Cooling hardens the wax which therefore facilitates smooth 
sectioning. 
(iii) Position block in microtome sample holder and begin to trim using large sections 
(up to 25 µm) until the surface on the tissue is exposed. 
(iv) Alter the microtome sectioning thickness appropriately, 5-10 µm is common in 
histopathology, and begin to cut sample ribbons. 
(v) Float individual ribbons in a heated sectioning bath at 40 - 44°C. 
▲CRITICAL STEP Gentle heat will help relax the wax and enable effective 
mounting. Heat must not surpass 45°C as the sample will begin to degenerate as the 
wax approaches its melting point. 
(vi) Carefully mount samples onto appropriate Raman substrate, by using the slide to lift 
the ribbon out of the water. 
▲CRITICAL STEP If the sample requires dewaxing proceed to step (vii), if not 
proceed to step (ix). 
(vii) Allow the slide to dry for 30 minutes. 
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▲CRITICAL STEP The sample must be adequately adhered to the slide surface 
prior to dewaxing, else the sample can be lost. 
(viii) Immerse the tissue in xylene for 5 minutes. Repeat twice to ensure wax is adequately 
removed. 
(ix) Clear xylene residues using a 15 minutes 100% ethanol wash, followed by a further 
15 minute wash with 90% ethanol and a final wash for 15 minutes with 70% ethanol. 
(x) Store at room temperature (20-22 °C) in a dry environment until analysis. 
■ PAUSE POINT Samples can be stored for up to one year, before significant 
degradation can occur. 
(C) SERS biofluids ● TIMING 10 min + drying (24 h) 
(i) Obtain biofluids specimen with suitable ethical approval. 
■ PAUSE POINT Samples can be stored at -80 °C for 1-2 years dependent upon 
license constraints. 
(ii) Apply 200 µl of biofluids and 200 µl of colloidal nanoparticles onto appropriate 
Raman substrate (volumes and ratios can be altered accordingly). 
▲CRITICAL STEP The user has three distinct methods for nanoparticle and 
sample mixture: (i) Apply nanoparticle solution to substrate, allow to dry and 
subsequently add sample; (ii) the reverse of the above process, where the sample is 
added first followed by the nanoparticles; or (iii) combine the two solutions together 
and apply mixture onto substrate. 
(iii) Allow to dry prior to analysis. Larger sample volumes require extended drying times 
and thus we recommend overnight as standard for continuity. 
(D) Cells ● TIMING 12 hr for cell attachment + 15 min sample prep 
■ PAUSE POINT splitting cells at approximately 60% confluence greatly diminishes 
the number of lipid droplets per cell, which can be caused by cell “stress”. 
(i) Seed a known number of cells onto the appropriate Raman substrate in 
supplemented cell culture media, under sterile conditions, and allow to incubate 
overnight at 37°C. 
(ii) After 12 hours or more, remove cells from incubator and aspirate off cell culture 
media. Wash samples with warmed sterile PBS. 
(iii) For live cell imaging, samples can be imaged in a warmed sterile PBS solution or 
warmed sterile filtered 0.9% NaCl saline solution. 
▲CRITICAL STEP Ensure all reagents are warmed to 37°C. Warming reagents to 
37°C reduces the shock to the cells and helps maintain overall morphology. 
(i) For cell fixation, after media has been removed, wash cells with warmed PBS.  
(ii) Immerse cells in warmed 10% formalin for 10 min for fixation. 
(iii) Wash thrice in warmed sterile PBS to remove any trace of the fixative.  
▲CRITICAL STEP Ensure all reagents are warmed to 37°C. Warming reagents to 
37°C reduces the shock to the cells and helps maintain overall morphology.  




■ PAUSE POINT Samples can be stored for up to 3 months at 4°C in sterile NaCl 
saline solution.   
 
Spectral acquisition 
2| Switch on Raman microspectrometer and open instrument operating software. 
▲CRITICAL STEP Carefully read the instrument operating manual and become aware of 
the operating features, specifications and safety operating procedures.  
3| Determine suitable instrumentation options, including laser wavelength, detector type and 
suitable optics. 
4| Calibrate and align the spectrometer using a calibration source.  
5| Mount the sample upon microscope stage for spectral acquisition. 
6| Using the microscope at a chosen magnification, examine the sample and focus upon a 
feature of interest. 
? TROUBLESHOOTING 
7| Determine the sampling area using the microscope and operating software using a point 
mapping (A) or imaging mapping (B) approach. 
(A) Point mapping ● TIMING 1 sec - 5 min (per spectrum) 
(i) Selectively, or randomly, chose numerous points in the sampling area to interrogate 
(anywhere between 5 and 50 spectra would be typical).  
▲CRITICAL STEP In SERS studies, enhanced spectra are obtained from 
molecules in close proximity to nanoparticles. In a point map approach we advise 
the user isolates nanoparticle aggregations and samples from this region. 
? TROUBLESHOOTING 
(B) Image mapping ● TIMING 1 sec - 1 min (per spectrum) 
(i) Select a mapping area using a ‘shape fill’ option (usually rectangular filled). 
(ii) Determine the number of spectra to be acquired within the mapping area by altering 
the step size. 
▲CRITICAL STEP Be aware of the sampling area in use (typically ~1 µm), as 
step sizes above this will result in under-sampling and below will result in over-
sampling. 
8| Input optimum spectral parameters to ensure best SNR, spectral quality within an 
appropriate acquisition time dependent upon the sample suitability. Determining the laser 
power at the sample using the designated spectral parameters may be conducted using a laser 
power meter.  
▲CRITICAL STEP Point mapping is generally less time restricted due to smaller spectra 
numbers and thus spectral quality should be optimised.  On the other hand, image mapping 
acquires a high number of spectra that can significantly elongate acquisition times and 
consequently a judgement between acquisition time and spectral quality should be made. 
Sample integrity must also be considered over long sampling periods. Furthermore, by 
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obtaining large numbers of spectra, multivariate approaches can extract much spectral detail 
from noisy data. 
9| Acquire sample measurement. 
? TROUBLESHOOTING 
10| Save measurements prior to data processing and convert to universal format if 
appropriate. 
■ PAUSE POINT Datasets can be stored until data processing 
Data pre-processing ● TIMING 10 – 60 min (dependent upon dataset size) 
▲CRITICAL STEP Steps 11-16 highlight possible pre-processing steps that can be 
performed on the spectral dataset in an advised order. All these steps are optional and can be 
applied in multiple combinations with varying effects on visual output. We recommend that 
the user observes the spectral output at each stage to inspect any adverse effects on the data 
sets. For further information, we direct the reader to Experimental design. data processing. 
11| Load data in selected data processing software (see Table 2). 
12| Screen the data for anomalies and poor quality spectra using quality tests. 
? TROUBLESHOOTING 
13| Apply a noise reduction technique on the dataset, such as PCA, to improve SNR. 
14| Conduct a baseline correction algorithm to account for fluorescence interference. 
15| Perform a data normalisation approach to account for confounding sample variables. 
16| If necessary, perform a data reduction technique such as simple truncation or PCA to 
reduce the number of variables in the dataset. 
Data analysis 
17| Choose an appropriate data analysis approach that will extract the required information 
from your point spectra or images, dependent upon the desired analysis goal. The options we 
describe here are exploratory analysis (A), for pattern finding and biomarker extraction, and 
diagnostic (B) analysis. For more information, please refer to Experimental design. Data 
processing. 
▲CRITICAL STEP All timings are estimated for typical datasets containing anywhere 
between 500 – 5000 spectra. Any deviations from this range will alter the timings 
accordingly. 
(A) Exploratory  ● TIMING 15 – 60 min (dependent upon dataset size) 
(i) Input pre-processed dataset into a feature extraction algorithm, either construction or 
selection. 
▲CRITICAL STEP For imaging, continue to step (ii); for point spectra, move to 
step (iv). 
(ii) For image analysis, use feature extraction outputs to assign a scalar value to each 
spectrum  (such as wavenumber intensities or PC score). 
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(iii) Use colour gradient, or code for scalar values. 
(iv) Visualise analysis output for biomarker and pattern extraction. 
(B) Diagnostic  ● TIMING 1 – 4 h (dependent upon dataset size) 
▲CRITICAL STEP For supervised classification, the dataset must be split into training 
and a test dataset. 
(i) Input pre-processed dataset into a feature extraction algorithm, either construction or 
selection, in training mode. 
(ii) Apply this trained feature extraction model to a training dataset. 
(iii) Train a classification algorithm using this training dataset. 
(iv) Input the test dataset into the trained FE model followed by the trained classification 
algorithm. 
▲CRITICAL STEP Cross-validation is recommended on small sample sizes.  
(v) Obtain a class estimation per spectrum. 
(vi) For imaging, this class estimation can be assigned a scalar value and visualized 
using a colour code. 
(C) Diagnosis (unsupervised) ● TIMING 15 – 60 min (dependent upon dataset size) 
(i) Use a clustering classification algorithm to categorize spectra based on spectral 
variance. 
(ii) Assign each cluster a numerical value/colour and visualize. 
? TROUBLESHOOTING 
Step 6| Maintaining optical focus 
It can be difficult to maintain optical focus if the sample is not secured sufficiently, or if the 
surface is not adequately flat, and can have significant impact on spectral quality. To improve 
stability, bulky samples should be held in place using magnets or weights when possible, or 
secured with adhesive materials such as tape. Small amount of mounting clay/putty on the 
underside of hard specimens may help secure them onto a substrate. This should also help 
flatten some samples, but it may be necessary to physically smooth sample surfaces, such as 
when analysing powders. Increased stability stages are available and are recommended in 
systems using high magnification (100×) as small stage movements can have more 
significant effects at high magnification. 
Step 7A(i)| Obtaining enhanced spectra 
As enhancement is reliant upon direct sampling of an area in close proximity to a 
nanoparticle, the probability of acquiring enhanced spectra is particularly low. We 
recommend isolating nanoparticle aggregates, which unlike monomers, may be visible under 
magnification. A good knowledge of the sample in question is needed, and we advise 
carefully studying subtle differences between control and SERS samples. The use of larger 
nanoparticles ( >100 nm) may also aid nanoparticle aggregate identification 62. Otherwise, 
using an automatic mapping procedure may produce enhanced spectra without the need of 
significant user input. 
 
Step 9| Insufficient spectral quality 
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As data is obtained, the user can identify four key indicators of spectral quality; (i) low SNR, 
(ii) fluorescent baseline, (iii) saturation of the CCD and (iv) photoablation. 
(i) Low SNR - Indicated by a strong background signal in comparison to Raman 
peaks, is indicative of insufficient Raman signal as a consequence of the sample or 
the experimental parameters. First, check that the system is appropriately aligned, 
that optical focus is optimised and the sample is illuminated by the laser. If 
possible, increase the laser power, followed by the exposure time and then an 
increased number of co-additions. If this is not possible, consider system 
alterations including an alternative laser wavelength or Raman approach that is 
better suited to your sample (Table 1). 
(ii) Fluorescence baseline - A range of fluorescence manifestation can be observed 
dependent upon the excitation wavelength in use, but is principally indicated by a 
strong, broad and featureless spectrum, similar to the fluorescence wavelength 
profile (Fig. 7A). Fluorescence is predominantly due to sample characteristics 
although can be influenced by background conditions, such as lights. We advise 
utilising a UV or NIR laser wavelength, or implementing an alternative Raman 
approach that can overcome fluorescence, such as SERS or SRS. Photobleaching 
may also reduce fluorescence contributions, with due caution of photoablation. 
(iii) Saturation of the CCD - Each CCD will have a limit to how many Raman scattered 
photons that it can measure, and when exceeded this can be observed by a feature 
such as a flat line effect on the spectrum (Fig. 7B). As saturation is indicative of 
increased Raman scattering, this issue is usually found in strong scattering 
materials, samples of a large volume and in SERS studies. This can be overcome 
by attenuating the laser power and/or exposure time upon the sample. Saturation 
cannot be corrected in post-acquisition processing. 
(iv) Photoablation - Some samples will be sensitive to high laser powers and thus can 
burn once exposed. Sometimes a burned sample will result in a saturated CCD and 
some residue may be on the objective. If a burned sample is observed, inspect the 
microscope objective for residue and the CCD signal for saturation. When this 
occurs visible damage to the sample can occur and increased intensity of 
amorphous carbon peaks. To avoid photodamage, the laser power and exposure 
times should be decreased accordingly, or a different laser wavelength could be 
used. If these approaches are inadequate, the laser power can be attenuated at the 
sample surface by using a larger laser spot, achieved by using a lower 
magnification setting or altering the laser focus. 
Step 12 | Spectral contaminants 
Cosmic rays or interference from sample contaminants can render spectra unusable unless 
they are removed. Cosmic rays can be identified as sharp spikes with narrow bandwidths that 
can often overshadow true Raman peaks (Fig. 7C). These should be removed using cosmic 
ray removal algorithms that are generally available in instrument operation software. Raman 
peaks associated with spectral contaminants such as paraffin (Fig. 7D), can occur due to 
inadequate sample preparation; however these can also be removed with respective 






We provide approximate times for each of the steps. All timing will be dependent upon the 
size of the dataset as sample processing and computational analysis are both proportional to 
the number of samples employed. 
Step 1A: 5 min 
Step 1B: 30 min - 2 h 
Step 1C: 10 min - 24 h 
Step 7A: 1 -5 min per spectrum (average 15 spectra per sample ~30 min) 
Step 7B: 1 sec - 1 min per spectrum (average 1000 spectra per sample ~3 hours) 
Steps 11-16: 10 min - 1 h 
Step 17A: 15 min - 1 h 
Step 17B: 1 - 4 h 
Step 17C: 15 min - 1 h 
Minimum experimental time of ~1 hour per sample 
Maximum experimental time of ~32 hours per sample 
Anticipated Results 
Pre-processing options 
Figure 5 is an example of the effects of pre-processing on spectra with strong fluorescence 
baseline interference (785 nm laser). Spectra were truncated to a defined spectral region 
(1700 - 700 cm-1) to account for Raman peaks present in this particular sample. A WDN step 
was conducted to smooth the appearance of the data and thus reduce unwanted noise. With 1st 
derivative baseline correction, the SG smoothing function is run simultaneously to account 
for loss of spectral quality using this approach. This example illustrates how effectively 
differentiation can account for baseline fluorescence, however spectral noise is increased and 
interpretability is reduced due to the transformation of the spectrum. On the other hand, 
polynomial baseline correction results in spectra with conventional appearance and 
sufficiently relieved of background interference. Vector normalisation was used in both 
incidences to attribute for confounding sample features, such as thickness; the effect of this is 
a slight reduction in variance between classes. 
Classification of blood plasma and serum using SERS 
Table 4 illustrates the effect of pre-processing, feature extraction and classification 
approaches on SERS of blood plasma and serum in endometrial cancer patients62. The 
classification rate was calculated by averaging the sensitivity (% of cancer spectra correctly 
defined as ‘cancer’) and specificity (% of control spectra correctly defined as ‘control’). The 
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purpose of this study was to determine if blood serum or plasma were significantly better at 
identifying endometrial cancer and whether surface enhancement contributed to improved 
enhancement. From this study, plasma samples produced improved classification rates 
compared to blood serum which can be associated with the inclusion of clotting proteins. A 
non-specific SERS labelling approach was used, which in this instance did not contribute to 
increased classification compared to the spontaneous Raman approach (control). The effect of 
pre-processing can be seen when comparing the classification rates in serum and plasma, with 
the former performing better with polynomial baseline correction and the latter performing 
best with differentiation correction. Generally, the classification approach used had a small 
effect on rates of classification, although this may not be the case in other circumstances. A 
variety of pre-processing and classification approaches should be employed and compared, in 
order to assess their diagnostic efficiency. 
Mapping of endometrial tissue 
Figure 6 depicts FFPE endometrial tissue in control patients in order to identify the epithelial 
lining of the endometrial crypts. These tissue structures seen throughout the three examples, 
are found ubiquitously throughout endometrial tissue initiating at the lumen and spiralling 
toward the myometrium (not visible). Each map was acquired using an increasing exposure 
time (1→3), ultimately increasing the spectral quality at each pixel. The Raman data was 
analysed using the multivariate technique PCA, with PC1 and PC2 effectively identifying the 
connective tissue (red) and the epithelial layer surrounding the crypt lumen despite alterations 
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Legends to figures 
Figure 1. Schematic identifying light scattering following laser exposure upon a sample 
surface.  Photons of light are focused upon the sample through the microscope objective at a 
defined magnification. When they interact with chemical bonds within the biological 
specimen, electrons are excited to virtual energy levels. These biological molecules return to 
the original energy level by emitting a photon of light, known as elastic or Rayleigh 
scattering, or it can undergo an energy shift and return at a lower (Stokes) or higher (anti-
Stokes) energy levels, known as Raman scattering. Fluorescence can occur when electrons 
are excited to electronic energy levels and return to the ground energy level by emitting a 
photon of light at a longer wavelength. 
Figure 2. Raman spectroscopy workflow diagram highlighting key aspects of experimental 
design including instrumentation, sample preparation, spectral acquisition and data 
processing with representative examples. It is not possible to conduct some options in 
combination, such as an InGaAs detector with UV wavelengths, and thus experimental design 
requires thorough planning prior to experimentation. Options provided are not exhaustive, 
and other alternatives are available. 
Figure 3. Generalised overview of instrumentation options within a typical spontaneous 
Raman spectroscopic microscope system. The beam path will be vary slightly between 
manufacturers and thus may contain additional optical components. 
Figure 4. Simplified overview of the effect of laser excitation wavelength on fluorescence 
background. Visible lasers are largely susceptible to background due to the defined 
wavelength profile of fluorescence (black), whereas high energy UV (purple) and lower 
energy IR (red) wavelengths are relatively free from fluorescence. 
Figure 5. A brief overview of pre-processing options in Raman spectral data analysis and 
their contribution to spectral transformation. Wavelet de-noising is conducted as a smoothing 
process, prior to polynomial baseline correction and vector normalisation. 1st order 
differentiation and Savitzky-Golay smoothing are conducted simultaneously to account for 
noise introduction in the spectra.  
Figure 6. Raman map of fixed endometrial tissue focusing upon uterine glands that spiral 
throughout the tissue. Samples are FFPE and were mounted upon BaF2 slides prior to 
dewaxing. (A) images are white light images of the tissues, whilst (B) displays PCA maps. 
Epithelial tissue is depicted in yellow, whereas connective tissue is shown in red. Spectra 
were all obtained using a 785 nm laser with 25 mW of power at the sample, a 1200 l/mm 
grating and a step size of 1 µm. (1B) was acquired with 5 seconds exposure time and is 
comprised of 47 × 48 pixels; (2B) 10 seconds, with 74 × 81 pixels; and (3B) 15 seconds, with 
55 × 53 pixels. 
Figure 7. Examples of common troubleshooting issues during spectral acquisition. (A) 
Shows typical fluorescence from a plant sample using a 785 nm laser; (B) saturation of a 
CCD detector; (C) cosmic ray at ~1220 cm-1 and; (D) paraffin contamination from an 
















































Table 1. Raman spectroscopy method variations and the respective experimental benefits and 
limitations. 







Non-linear approach that utilises 
multiple laser frequencies; a pump 
(ωp) and Stokes (ωs) field that 
combine, tuned to a frequency 
equivalent to a specific molecular 
vibration, thus generating a strong 
anti-Stokes signal (ωas = 2ωp-ωs) 
that detects vibrational coherence 


















Addition of a confocal microscope 
that allows depth measurements 
within tissue. A pinhole is used 
within the spectrometer to reject 
stray light, effectively reducing the 
collimation of the beam and 
information to be derived from an 
alternative focal plane 
High sensitivity 




















Sample preparation for fluid 
analysis that drops a small volume 
of sample onto a flat substrate and 
allows to dry 
Accurate preparation of 
biofluids 
Small volumes of fluid 
required (2 – 10 µl) 
Not completely free 





`FT-Raman Non-dispersive system that utilises 
Fourier transformation using a 
Michaelson interferometer 
High throughput  
High resolution 
Free from fluorescence  
Low scattering 
intensity 










A linear technique using repeated 
laser pulses and a Kerr gate that 
capture Raman light temporally (up 





Not completely free 
from fluorescence 
Better performance 
when in conjunction 
with SERDS 
Depth profiling in 







Polarised light with a specific 
electric field vector will only obtain 
spectral information from specific 
vibrational modes dependent on 
their orientation in relation to the 
incident beam 
Information regarding 
molecular structure and 
orientation 











Using right- and left-circularly 
polarised incident light, the small 
changes in Raman scattering can be 
indicative of optical activity of 
discrete molecular vibrations. 
Structural information 
from specific 
conformations of chiral 
molecules 
Circular intensity 
differences are very 
small 
Vibrational coupling 
in ROA signals can 










Exploits the ‘resonance effect’ 
observed when the laser frequency 
matches (or approaches) that of an 
electronic transition of the sample 
or compound in question 
Up to 6 orders of 















Nonlinear approach that obtains 
two spectra at marginally different 
laser frequencies and creates a 
difference spectrum by subtracting 







Prone to error 
Live cell 182 
Animal tissue183 








Continuous, low intensity laser 
beams are employed to illuminate 
the surface of the sample and 
Raman spectra are then derived at 
distinct distances away from this 
point. A scaled subtraction between 
these spectra reveals alterations 
indicative of the underlying sub-
surface layers 















A combination of SERS and SORS 
approaches, able to detect SERS 
nanoparticles introduced into turbid 
samples 
Detect SERS signals up to 











Nonlinear approach using a pump 
(ωp) and Stokes (ωs) field that are 
tuned to a defined frequency 
representative of a molecular 
vibrations (ωp- ωs). When this 
occurs ωp observes a stimulated 
Raman loss (SRL) in energy, and ωs 
observes a stimulated Raman gain 
(SRG). The transferred intensity is 
proportional to the biochemical 
constituents 
Not affected by 
fluorescence and 
nonresonant background 
High sensitivity (1 in 106  
photons) 
High spatial resolution 
Prone to interference 
from strong Raman 
scatterers 
Limited to 
measurement of one 












Due to surface plasmon resonance, 
a metal surface with nanoscale 
roughness can significantly increase 
the electric field when excited by a 
laser. Thus when adsorbed to a 
biomolecule, these nanoparticles 
result in greatly enhanced Raman 
scattering 
103 – 1010 enhancement 
Below diffraction limit 
resolution 





Can reduce band 







Tumour targeting198  















Combination of SERS and RRS, 
where the laser frequency  
Up to 1015 enhancement205 
Cumulative benefits of 













Based upon the same 
electromagnetic and chemical 
theory as SERS, TERS utilises an 
atomic force microscope (AFM) tip 
coated with SERS active metal. 
When placed into close proximity 
to the sample, it results in enhanced 
scattering 
Tip dependent spatial 
resolution.  
Low detection limit 
Quench fluorescence 















The sample is placed in contact 
with a reflective prism, through 
which a laser beam is reflected, 
producing an evanescent wave that 
penetrates the sample below 








Raman scattered light is captured 
on the opposite side of laser 
illumination 
Depth measurements up to 
30 mm 















Table 2. Data analysis software for Raman spectral datasets 





































































Table 3. Commercially available instruments and corresponding operational software. 
Manufacturer Instruments  Software 
BaySpec Agility™ 
RamSpec™  






















Horiba Scientific XploRA™ Series 
LabRAM HR Evolution 
Triple Raman Spectrometers 







JASCO NRS-5000 Series Raman 































Renishaw InVia confocal Raman microscope 

















FirstDefender™ RM Chemical 
Identification System 




















Table 4. Classification rates (% classification ± standard deviation) of control and 
endometrial cancer patients from blood serum and plasma samples, using surface enhanced 
Raman spectroscopy (SERS) with two different diameter gold nanoparticles and spontaneous 
Raman (‘No SERS’). Two pre-processing approaches and two classification approaches are 
used to illustrate varied performances. Polynomial baseline correction was conducted with a 
polynomial order of 5 and first order Savitzky-Golay (SG) differentiation used 9 filter co-
efficients with a polynomial order of two. A support vector machine (SVM; optimised C and 
ɣ parameters) classifier was implemented without a feature extraction step, whereas principal 
component analysis (PCA; optimised number of PCs) was employed prior to a linear 
discriminant classifier (LDC). The cells are colour coded dependent upon the classification 
rate (yellow to red). 
   
Classification Approach (%) 





Polynomial → Vector 
Normalisation 
No SERS 89.58 ± 07.18 88.56 ± 11.35 
40 nm 69.42 ± 08.37 59.69 ± 19.24 




No SERS 79.63 ± 09.23 79.79 ± 11.46 
40 nm 65.74 ± 09.40 65.83 ± 26.17 





Polynomial → Vector 
Normalisation 
No SERS 97.28 ± 03.87 93.55 ± 08.18 
40 nm 79.30 ± 11.10 79.79 ± 14.27 




No SERS 98.50 ± 02.69 95.07 ± 05.15 
40 nm 80.02 ± 10.39 79.11 ± 13.77 
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